share_log

Moderna shares are trading higher after French health officials on Thursday said an mRNA vaccine can be used in place of the second shot from AstraZeneca. Additionally, White House COVID-19 Response C

Moderna shares are trading higher after French health officials on Thursday said an mRNA vaccine can be used in place of the second shot from AstraZeneca. Additionally, White House COVID-19 Response C

在法國衞生官員週四表示，可以使用mRNA疫苗來取代阿斯利康(AstraZeneca)的第二針疫苗後，現代股票交易走高。此外，白宮新冠肺炎迴應C
Benzinga ·  2021/04/09 23:24

Moderna shares are trading higher after French health officials on Thursday said an mRNA vaccine can be used in place of the second shot from AstraZeneca. Additionally, White House COVID-19 Response Coordinator Jeff Zients recently said the US in on track of meeting the goal of 100 million shots in 100 days.

在法國衞生官員週四表示，可以使用mRNA疫苗來取代阿斯利康(AstraZeneca)的第二針疫苗後，現代股票交易走高。此外，白宮新冠肺炎迴應協調員傑夫·齊恩茨最近表示，美國有望在100天內實現1億次拍攝的目標。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論